Curaleaf to buy cannabis company Emmac Life Sciences
March 11, 2021
US cannabis product supplier Curaleaf Holdings has agreed to buy UK peer Emmac Life Sciences for $286 million in a cash-and-share-deal. An extra $57 million will be paid in Curaleaf subordinate voting shares and cash if certain performance milestones are reached. The deal marks Curaleaf's entry into the growing European cannabis market.